Efficacy of a second biologic treatment in androgen receptor-positive (AR+) recurrent/metastatic salivary duct carcinoma (RMSDC)

Authors :: Luca Raimondo
Elisa Bellini
Giancarlo Pecorari
Viviana Contu
Fulvia Pedani
Massimiliano Garzaro
Mario Airoldi
Source :: Journal of Clinical Oncology. 32:e17055-e17055
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: e17055 Background: AR+ RMSDC can be treated with an approach including anti-androgen drugs. In case of progression a 2nd line with palliative chemotherapy can be proposed. We report 3 cases of a 2n...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
fungi
food and beverages
Androgen Receptor Positive
Palliative chemotherapy
Biologic treatment
medicine.disease
Salivary duct carcinoma
Internal medicine
medicine
business

Full Text Access

Tools